Stock Code: 002173 Stock Abbreviation: Innovation Medical Announcement No.: 2026-007
Innovation Medical Management Co., Ltd. Announcement on Providing Guarantee for Hongrun Pharmaceutical
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
Overview of the Guarantee
Innovation Medical Management Co., Ltd. (hereinafter referred to as the "Company")'s wholly-owned subsidiary, Zhejiang Hongrun Pharmaceutical Co., Ltd. (hereinafter referred to as "Hongrun Pharmaceutical"), needs to apply for a loan of RMB 10 million from the Juxian Branch of Beijing Bank Co., Ltd. (hereinafter referred to as "Beijing Bank Juxian Branch") within a credit line of RMB 10 million for one year due to production and operation needs. On February 10, 2026, the Company held the first extraordinary meeting of the seventh Board of Directors in 2026, which deliberated and passed the "Proposal on Providing Guarantee for Hongrun Pharmaceutical." It was agreed that the Company would provide a guarantee for Hongrun Pharmaceutical's loan application within the credit line of RMB 10 million from Beijing Bank Juxian Branch.
The total amount of this guarantee is RMB 10 million, which does not exceed 10% of the Company's net assets as of the most recent audited period. After the deliberation and approval of this guarantee proposal by the Board of Directors, the Company's total guarantee amount will be RMB 53.20 million, which does not exceed 50% of the Company's net assets as of the most recent audited period, nor does it exceed 30% of the Company's total assets as of the most recent audited period. The asset-liability ratio of Hongrun Pharmaceutical in the most recent period did not exceed 70%. According to the "Shenzhen Stock Exchange Stock Listing Rules," "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 1 - Standardized Operation of Main Board Listed Companies," and other laws, regulations, and normative documents, as well as the Company's "Articles of Association," the above guarantee matters do not need to be submitted for deliberation by the Company's shareholders' meeting.